Serum levels of soluble CD30 in chronic hepatitis B virus infection

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 105-110

  Fattovich, G ^a   Vinante, F ^a   Giustina, G ^b   Morosato, L ^a   Alberti, A ^b   Ruol, A ^b   Pizzolo, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chronic hepatitis B; Humoral immunity; Soluble CD30; T helper type 2

Indexed keywords

ALPHA INTERFERON; CD30 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HELPER CELL; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030051014     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.915607.x     Document Type: Article

References (32)

1. Fattovich G, Rugge M, Brollo L et al. Clinical, virologic and histologic outcome following seroconvcrsion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986; 6:167-72.
2. Lok ASF, Hadziyannis SJ, Weller IVD et al. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut 1984; 25:1283-7.
3. Fattovich G, Brollo L, Alberti A, Pontisso P, Giustina G, Realdi G. Long-term follow-up of anti-HBe-positive chronic active hepatitis B. Hepatology 1988; 8:1651-4.
4. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of hepatitis Bc antigen in patients with chronic hepatitis B infection. Lancet 1989; 2:588-90.
5. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
6. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type I infection. J Exp Med 1994; 180:489-95.
7. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992; 68:421-7.
8. Schwab U, Stein H, Gerdes J et al. Production of a monoclonal antibody specific for Hodgkin's and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299:65-67.
9. Stein H, Mason DY, Gerdes J et al. The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that the Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66:848-58.
10. Josimovic-Alasevic O, Durkop H, Schwarting R, Backè E, Stein H, Diamanstein T. Ki-1 (CD30) antigen is released by Ki-1 positive tumor cells in vitro and in vivo. Partial characterisation of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol 1989; 19:157-62.
11. Falini B, Pileri S, Pizzolo G et al. CD30 (ki-1) molecule: a new cytokine receptor of the TNF receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85:138-43.
12. + T cell clones in human immunodeficiency virus (HIV) infection. J Exp Med 1994; 180:2407-11.
13. + T cells producing Th2-type cytokines. FASEB J 1995; 9:81-86.
14. Pizzolo G, Vinante F, Morosato L et al. High serum levels of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994; 8:741-5.
15. Del Prete G, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995; 16:76-80.
16. Fattovich G, Brollo L, Boscaro S et al. Long-term effect of low dose recombinant inlerferon therapy in patients with chronic hepatitis B. J Hepatol 1989; 9:331-7.
17. Fattovich G, Giustina G, Brollo L et al. Therapy for chronic hepatitis B with lymphoblastoid interferon-α and levamisole. Hepatology 1992; 16:1115-9.
18. Alberti A, Pontisso P, Fattovich G et al. Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long term follow-up study of 138 patients. J Infect Dis 1986; 154:562-9.
19. Bianchi L, De Groote J, Desmet VJ et al. Acute and chronic hepatitis revisited. Lancet 1977; 2:914-9.
20. Scheuer P. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13:372-4.
21. Mondelli M, Mieli-Vergani G, Alberti A et al. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells arc directed against HBV core antigen expressed on hepatocytes. J Immunol 1982; 129:2773-7.
22. Penna A, Chisari F, Bertoletti A et al. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174:1565-70.
23. Bertoletti A, Ferrari C, Fiaccadori F et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 1991; 88:10445-9.
24. Missale G, Redeker A, Person J et al. HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid wpitopw during acute viral hepatitis. J Exp Med 1993; 177:751-62.
25. Ferrari C, Penna A, Bertoletti A et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145:3442-9.
26. Paul WF, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76:241-51.
27. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993; 91:2586-95.
28. Milich DR, McLachlan A, Stahl S et al. Comparative immunogenicity of hepatitis B virus core and e antigens. J Immunol 1988; 141:3617-24.
29. Ferrari C, Bertoletti A, Penna A et al. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 1991; 88:214-22.
30. Maruyama T. Iino S, Koike K, Yasuda K, Milich DR. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 1993; 105:1141-51.
31. Clerici M, Hakim FT, Venzon DJ et al. Changes in interleukin-2 and inlerleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91:759-65.
32. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152:3074-87.